• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶激活受体 1(PAR1)信号转导脱敏可通过人血小板中的 PAR4 信号转导来拮抗。

Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets.

机构信息

Department of Clinical and Experimental Medicine, Division of Clinical Chemistry, Medical Faculty, University of Linköping, University Hospital, Linköping 581 85, Sweden.

出版信息

Biochem J. 2011 Jun 1;436(2):469-80. doi: 10.1042/BJ20101360.

DOI:10.1042/BJ20101360
PMID:21391917
Abstract

PARs (protease-activated receptors) 1 and 4 belong to the family of G-protein-coupled receptors which induce both G(α12/13) and G(αq) signalling. By applying the specific PAR1- and PAR4-activating hexapeptides, SFLLRN and AYPGKF respectively, we found that aggregation of isolated human platelets mediated via PAR1, but not via PAR4, is abolished upon homologous receptor activation in a concentration- and time-dependent fashion. This effect was not due to receptor internalization, but to a decrease in Ca²⁺ mobilization, PKC (protein kinase C) signalling and α-granule secretion, as well as to a complete lack of dense granule secretion. Interestingly, subthreshold PAR4 activation rapidly abrogated PAR1 signalling desensitization by differentially reconstituting these affected signalling events and functional responses, which was sufficient to re-establish aggregation. The lack of ADP release and P2Y₁₂ receptor-induced G(αi) signalling accounted for the loss of the aggregation response, as mimicking G(αi/z) signalling with 2-MeS-ADP (2-methylthioadenosine-5'-O-diphosphate) or epinephrine (adrenaline) could substitute for intermediate PAR4 activation. Finally, we found that the re-sensitization of PAR1 signalling-induced aggregation via PAR4 relied on PKC-mediated release of both ADP from dense granules and fibrinogen from α-granules. The present study elucidates further differences in human platelet PAR signalling regulation and provides evidence for a cross-talk in which PAR4 signalling counteracts mechanisms involved in PAR1 signalling down-regulation.

摘要

蛋白酶激活受体 (PARs) 1 和 4 属于 G 蛋白偶联受体家族,可诱导 G(α12/13)和 G(αq)信号转导。通过应用特异性 PAR1 和 PAR4 激活六肽 SFLLRN 和 AYPGKF,我们发现,通过 PAR1 介导的人血小板分离物的聚集,而不是通过 PAR4 介导的聚集,在同源受体激活时,以浓度和时间依赖的方式被废除。这种效应不是由于受体内化,而是由于 Ca²⁺动员、PKC(蛋白激酶 C)信号转导和α-颗粒分泌减少,以及致密颗粒分泌完全缺失。有趣的是,亚阈值 PAR4 激活通过差异重建这些受影响的信号事件和功能反应,迅速消除 PAR1 信号脱敏,足以重新建立聚集。缺乏 ADP 释放和 P2Y₁₂受体诱导的 G(αi)信号转导是聚集反应丧失的原因,因为用 2-MeS-ADP(2-甲基硫腺苷-5'-O-二磷酸)或肾上腺素(肾上腺素)模拟 G(αi/z)信号转导可以替代中间 PAR4 激活。最后,我们发现,通过 PAR4 重新敏化 PAR1 信号诱导的聚集依赖于 PKC 介导的致密颗粒中 ADP 和α-颗粒中纤维蛋白原的释放。本研究进一步阐明了人血小板 PAR 信号转导调节的差异,并提供了证据表明 PAR4 信号转导相互作用可以抵消 PAR1 信号转导下调所涉及的机制。

相似文献

1
Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets.蛋白酶激活受体 1(PAR1)信号转导脱敏可通过人血小板中的 PAR4 信号转导来拮抗。
Biochem J. 2011 Jun 1;436(2):469-80. doi: 10.1042/BJ20101360.
2
Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.通过分隔的环核苷酸作用对人血小板中蛋白酶激活受体(PAR)1和PAR4信号传导的调节
J Pharmacol Exp Ther. 2007 Aug;322(2):778-88. doi: 10.1124/jpet.107.121830. Epub 2007 May 24.
3
The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.三磷酸腺苷(ATP)门控的P2X1受体在凝血酶和肾上腺素激活经阿司匹林处理的血小板过程中起关键作用。
J Biol Chem. 2008 Jul 4;283(27):18493-504. doi: 10.1074/jbc.M800358200. Epub 2008 May 14.
4
Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.通过蛋白酶激活受体4(PAR4)的血小板活化参与凝血酶生成的起始过程以及血凝块弹性的形成。
Thromb Haemost. 2007 Mar;97(3):417-24.
5
[Role of adenosine diphosphate in the course of thrombin signal transmission].[二磷酸腺苷在凝血酶信号传导过程中的作用]
Zhonghua Yi Xue Za Zhi. 2006 Dec 12;86(46):3299-301.
6
Inhibition of PAR4 signaling mediates ethanol-induced attenuation of platelet function in vitro.PAR4信号传导的抑制介导了乙醇在体外诱导的血小板功能减弱。
Alcohol Clin Exp Res. 2006 Sep;30(9):1608-14. doi: 10.1111/j.1530-0277.2006.00193.x.
7
Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.PAR1拮抗剂、PAR4拮抗剂及其组合对凝血酶诱导的人血小板活化作用的比较。
Eur J Pharmacol. 2006 Sep 28;546(1-3):142-7. doi: 10.1016/j.ejphar.2006.07.004. Epub 2006 Jul 14.
8
Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter.蛋白酶激活受体-1(PAR1)和PAR2而非PAR4介导食管下括约肌的舒张。
Regul Pept. 2007 Jul 5;142(1-2):37-43. doi: 10.1016/j.regpep.2007.01.004. Epub 2007 Jan 31.
9
Thrombin receptor levels in platelet concentrates during storage and their impact on platelet functionality.血小板储存过程中血小板浓缩物中的凝血酶受体水平及其对血小板功能的影响。
Transfusion. 2012 Jun;52(6):1253-9. doi: 10.1111/j.1537-2995.2011.03475.x. Epub 2012 Jan 10.
10
Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.中性粒细胞蛋白酶可使人类PAR3失活,并消除PAR3在小鼠血小板上的共受体功能。
Thromb Haemost. 2001 Mar;85(3):533-8.

引用本文的文献

1
Platelet Aggregation Alterations in Patients with Severe Viral Infection Treated at the Intensive Care Unit: Implications for Mortality Risk.重症监护病房治疗的严重病毒感染患者血小板聚集的改变:对死亡风险的影响
Pathogens. 2024 Sep 10;13(9):778. doi: 10.3390/pathogens13090778.
2
Loss of P2Y receptor desensitization does not impact hemostasis or thrombosis despite increased platelet reactivity in vitro.尽管体外血小板反应性增加,但 P2Y 受体脱敏丧失并不影响止血或血栓形成。
J Thromb Haemost. 2023 Jul;21(7):1891-1902. doi: 10.1016/j.jtha.2023.03.013. Epub 2023 Mar 21.
3
Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.
新冠病毒病(COVID-19)中的血栓形成事件与住院前预防性抗凝药物使用较少相关,且随后血小板反应性降低。
Front Med (Lausanne). 2021 Apr 22;8:650129. doi: 10.3389/fmed.2021.650129. eCollection 2021.
4
Gradient-dependent inhibition of stimulatory signaling from platelet G protein-coupled receptors.血小板 G 蛋白偶联受体刺激信号的梯度依赖性抑制。
Haematologica. 2019 Jul;104(7):1482-1492. doi: 10.3324/haematol.2018.205815. Epub 2019 Jan 10.
5
The protease-activated receptor 4 Ala120Thr variant alters platelet responsiveness to low-dose thrombin and protease-activated receptor 4 desensitization, and is blocked by non-competitive P2Y inhibition.蛋白酶激活受体 4 第 120 位的丙氨酸突变为苏氨酸变异体改变了血小板对低剂量凝血酶和蛋白酶激活受体 4 脱敏的反应性,并且被非竞争性 P2Y 抑制所阻断。
J Thromb Haemost. 2018 Dec;16(12):2501-2514. doi: 10.1111/jth.14318. Epub 2018 Nov 22.
6
Contributions of Protease-Activated Receptors PAR1 and PAR4 to Thrombin-Induced GPIIbIIIa Activation in Human Platelets.蛋白酶激活受体PAR1和PAR4对凝血酶诱导的人血小板糖蛋白IIbIIIa激活的作用
Mol Pharmacol. 2017 Jan;91(1):39-47. doi: 10.1124/mol.116.106666. Epub 2016 Oct 26.
7
Protease-activated receptor 4: from structure to function and back again.蛋白酶激活受体4:从结构到功能,再回归结构
Br J Pharmacol. 2016 Oct;173(20):2952-65. doi: 10.1111/bph.13455. Epub 2016 Mar 10.
8
Thrombin-induced reactive oxygen species generation in platelets: A novel role for protease-activated receptor 4 and GPIbα.凝血酶诱导血小板中活性氧的产生:蛋白酶激活受体4和糖蛋白Ibα的新作用。
Redox Biol. 2015 Dec;6:640-647. doi: 10.1016/j.redox.2015.10.009. Epub 2015 Oct 28.
9
Protease-activated receptor 4: a critical participator in inflammatory response.蛋白酶激活受体 4:炎症反应的关键参与者。
Inflammation. 2015 Apr;38(2):886-95. doi: 10.1007/s10753-014-9999-6.
10
Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model.使用基于主体的模型研究血小板-肿瘤细胞相互作用在转移进展中的关键作用。
Theor Biol Med Model. 2014 Apr 12;11:17. doi: 10.1186/1742-4682-11-17.